KMT2A and leukemia: While in leukemia cells with AML1-ETO and PML-RARa fusion proteins inhibition of PARP leads to an accumulation of DNA damage that results in cell differentiation and cell death, leukemia cells expressing MLL fusion proteins exhibit resistance to inhibition of PARP (Yeung et al., 2010).